Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY: HLN )

10.08 +0.18 (+1.82%)
Official Closing Price Updated: 7:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,911,174
Open 9.990
Bid (Size) 9.830 (1)
Ask (Size) 10.11 (1)
Prev. Close 9.900
Today's Range 9.970 - 10.09
52wk Range 7.890 - 10.80
Shares Outstanding N/A
Dividend Yield 1.01%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
Dr. Reddy's Q3 FY2025 revenue reached $977 million, up 16%, with $165M net income. Growth fueled by NRT portfolio and global generics expansion. 
Via Benzinga
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS. 
Via Investor's Business Daily

Performance

YTD
+6.78%
+6.78%
1 Month
+7.35%
+7.35%
3 Month
+5.22%
+5.22%
6 Month
+2.13%
+2.13%
1 Year
+21.89%
+21.89%

More News

Read More
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
Via Benzinga
What's Going On With Kenvue Stock Monday?
Via Benzinga
Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Top 2 Risk Off Stocks That May Implode In August
Via Benzinga
Current Analysis: Haleon
Via Talk Markets
Earnings Scheduled For February 29, 2024
Via Benzinga
Haleon Earnings Preview
Via Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Via Benzinga
4 Reasons Pfizer Could Be a Value Play You Can't Miss
Via MarketBeat
Exposures COVID-19 Product Safety
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
Via Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Via Benzinga
Peering Into Haleon's Recent Short Interest
Via Benzinga
How Is The Market Feeling About Haleon?
Via Benzinga
Upcoming Stock Spinoffs: Should You Pounce or Pass?
Via InvestorPlace
Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M
Via Benzinga
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
Via Benzinga
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
Via Benzinga
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
Via Benzinga
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
Advil Maker Haleon Expects Higher 2024 Revenue After Strong 2023 Earnings, Stock Soars
Via Benzinga
Robitussin Recall 2024: What to Know About the New Cough Syrup Recalls
Via InvestorPlace
Robitussin Recall: Here Are The Products Impacted And What You Need To Know
Via Benzinga
GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.